BGI’s Goal: Customize Humans and Synthesize Biochemical Weapons (Part 1)

A laboratory technologist working on samples to be tested for the new coronavirus at "Fire Eye" laboratory in Wuhan, Hubei Province. BGI Group, a genome sequencing company based in southern China, said it opened a lab in Wuhan on Feb. 5 that is able to test up to 10,000 people per day for the virus. STR/AFP via Getty Images

News Analysis

This is the first of three articles that introduce readers to the research and mission of BGI Group, China’s leading genome sequencing company with customers around the globe. Its research involves collecting, studying, and altering human and animal genes to facilitate such things as biochemical weapons development and even customizing humans.